Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy

Journal of the American College of Cardiology

Volumn 36, Issue 5, 2000, Pages 1536-1541

  Sabaté, Manel ^a   Costa, Marco A ^a   Kozuma, Ken ^a   Kay, I Patrick ^a   Van Der Wiel, Connie J ^b   Verin, Vitali ^c   Wijns, William ^d   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CARDIALYSIS   (Netherlands)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANGIOPLASTY, BALLOON; CARDIOLOGY; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 0034331407     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00893-7     Document Type: Article

References (27)

1. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: A quantitative angiographic study in 1445 successfully dilated lesions
2. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy
3. Restenosis after coronary angioplasty: The paradox of increased lumen diameter and restenosis
4. Quantitative coronary arteriographic methods in the interventional catheterization laboratory: An update and perspective
5. Comparison of quantitative coronary angiography to visual estimates of lesion severity pre- and post-PTCA
6. Quantitative coronary angiography (QCA) in interventional cardiology: Clinical application of QCA measurements
7. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study
8. Quantitative assessment with ultracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
9. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy
10. Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans
11. Geometric vascular remodeling in patients treated with balloon angioplasty followed by beta-radiation therapy: A three-dimensional ultrasound study
12. Intracoronary beta-irradiation to reduce restenosis after balloon angioplasty: Results of a multicenter European Dose-Finding Study
13. Schneider-Sauerwein intravascular radiation system
14. Experimental validation of geometric and densitometric coronary measurements on the new generation Cardiovascular Angiography Analysis System (CAAS II)
15. Calibration using angiographic catheters as scaling devices: Importance of filming the catheters not filled with contrast medium
16. Geographic miss: A cause of treatment failure in radio-oncology applied to intracoronary radiation therapy
17. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (BENESTENT-II)
18. Change in diameter of coronary artery segments adjacent to stenosis after percutaneous transluminal coronary angioplasty: Failure of percent diameter stenosis measurements to reflect morphologic changes induced by balloon dilation
19. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: Quantitative angiographic analysis in 778 lesions - Further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis)
20. Primary stenting versus balloon angioplasty in occluded coronary arteries. The Total Occlusion Study of Canada (TOSCA)
21. Inhibition of restenosis with beta-emitting radiation (32P): The final report of the PREVENT trial
22. 32 beta-radiotherapy on both vessel remodeling and neointimal hyperplasia after coronary balloon angioplasty and stenting. A three-dimensional intravascular ultrasound investigation
23. Prevention of restenosis after percutanous transluminal coronary angioplasty with thromboxane A2-receptor blockade: A randomized, double-blind, placebo-controlled trial
24. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter randomized, double-blinded, placebo-controlled trial
25. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: A multicenter randomized double-blind, placebo-controlled trial
26. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial